COMMUNIQUÉS West-GlobeNewswire
-
Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation
10/02/2026 -
Newsweek Names Chicago Plastic Surgeons Best in America for 11 Procedures
10/02/2026 -
Nebraska Remains a National Outlier in Certified Nurse-Midwife Regulation
10/02/2026 -
Miami Startup Launches First At-Home Gut Test Designed Specifically for Cognitive Wellness
10/02/2026 -
IBA – ACQUISITION OF OWN SHARES
10/02/2026 -
IBA – ACQUISITION D’ACTIONS PROPRES
10/02/2026 -
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
10/02/2026 -
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
10/02/2026 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026
10/02/2026 -
Hyagen Medical Launches National FDA Compliance and Education Initiative to Strengthen Regenerative Medicine Standards
10/02/2026 -
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart
10/02/2026 -
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
10/02/2026 -
Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
10/02/2026 -
Hassan Spine & Sports Medicine Rebrands as NefraHealth
10/02/2026 -
Press Release: Sanofi completes the acquisition of Dynavax
10/02/2026 -
BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion
10/02/2026 -
Communiqué de presse : Sanofi finalise l’acquisition de Dynavax
10/02/2026 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
10/02/2026 -
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
10/02/2026
Pages